SARS-CoV-2-IN-25

SARS-CoV-2-IN-25

• UNSPSC Description: SARS-CoV-2-IN-25 (Compound CP026) is a potent SARS-CoV-2 spike pseudoparticle transduction inhibitor with an IC50 of 1.6 μM. SARS-CoV-2-IN-25 inhibits enveloped viruses and liposomes[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-in-25.html
• Solubility: 10 mM in DMSO
• Smiles: OP(OC1=C2C(C3C4=C(C2C3)C=C5C(C6C7=C(C5C6)C=CC=C7)=C4)=C(C8=C1C9C%10=CC(C%11CC%12C%13=C%11C=CC=C%13)=C%12C=C%10C8C9)OP(OCCC%14=CC=CC=C%14)(O)=O)(OCCC%15=CC=CC=C%15)=O
• Molecular Weight: 934.94
• References & Citations: [1]Weil T, et al. Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses. JACS Au, 2022.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported